Clinical use of recombinant human TSH in thyroid cancer patients |
| |
| Authors: | Schlumberger M Ricard M Pacini F |
| |
| Affiliation: | Department of Nuclear Medicine and Endocrine Tumors, Institut Gustave Roussy, 94805 Villejuif, Cèdex France. schlumbg@igr.fr |
| |
| Abstract: | Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal during the post-surgical follow-up of papillary and follicular thyroid cancer. Its clinical efficiency for the detection of persistent and recurrent disease is similar to that of thyroid hormone withdrawal. The main purpose for its use is to avoid hypothyroidism. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
